Abstract:Summary Background ALKBH5 belongs to the ALKB family consists of a Fe (II) and a-ketoglutarate-dependent dioxygenase. ALKBH5 directly catalyzes the oxidative demethylation of m6A-methylated adenosine. ALKBH5 involves in tumorigenesis and tumor progression, and is often dysregulated in a wide range of cancers, including colorectal cancer. Emerging evidence indicates that the expression of ALKBH5 is associated with the abundance of infiltrating immune cells in the microenvironment. However, how ALKBH5 affects immune cell infiltration in the microenvironment in colorectal cancer (CRC) has not been reported. The aim of this study was to identify how the expression of ALKBH5 affects the biological behaviors of CRC cell lines and regulates the effects on infiltrating CD8 + T cells in CRC microenvironment with its specific mechanism. Methods Firstly, the transcriptional expression profiles of CRC were downloaded from TCGA database and integrated via R software (4.1.2). Between CRC and normal colorectal tissues, ALKBH 5 mRNA expressions were compared (Wilcoxon rank-sum). We further identified the expression levels of ALKBH5 in CRC tissues and cell lines through quantitative PCR, western blot, and immunohistochemistry. Then, how ALKBH5 affects the biological behaviors of CRC cells were confirmed by gain- and loss-of-function analysis. Furthermore, the relationship between ALKBH5 level and 22 tumor-infiltrating immune cells was examined through CIBERSORT in R software. Furthermore, we explored the correlation between ALKBH5 expression and tumor-infiltrated CD8 + , CD4 + and regulatory T cells by utilizing the TIMER database. Finally, the association between chemokines and CD8 + T cells infiltration in CRC was analyzed using GEPIA online database. qRT-PCR, WB and IHC were used to further determine the effect of ALKBH5 on NF-κB-CCL5 signaling axis and CD8 + T cells infiltration. Results Clinically, ALKBH5 expression was downregulated in CRC and low levels of ALKBH5 expression were correlated with poor overall survival (OS). Functionally, overexpression of ALKBH 5 reduced the proliferation, migration and invasion of CRC cells, and vice versa. Overexpression of ALKBH 5 suppresses NF-κB pathway, thus reduces CCL5 expression and promotes CD8 + T cells infiltration in CRC microenvironment. Conclusions ALKBH5 is poorly expressed in CRC, and overexpression of ALKBH 5 attenuates CRC malignant progression by inhibiting CRC cell proliferation, migration, invasion and promoting CD8 + T cells infiltration in the tumor microenvironment through NF-κB-CCL5 axis.

ALKBH5-mediated m6 A demethylation of TIRAP mRNA promotes radiation-induced liver fibrosis and decreases radiosensitivity of hepatocellular carcinoma

ALKBH5‐mediated m6A demethylation of TIRAP mRNA promotes radiation‐induced liver fibrosis and decreases radiosensitivity of hepatocellular carcinoma

Lncrna MIR22HG-Derived Mir-22-5p Enhances the Radiosensitivity of Hepatocellular Carcinoma by Increasing Histone Acetylation Through the Inhibition of HDAC2 Activity

ALKBH5-Modified HMGB1-STING Activation Contributes to Radiation Induced Liver Disease Via Innate Immune Response.

m<SUP>6</SUP>A demethylase ALKBH5 attenuates doxorubicin-induced cardiotoxicity via posttranscriptional stabilization of Rasal3

M6a Demethylase Alkbh5 Promotes Radiation-Induced Live Disease By Modification Of Hmgb1 Demethylation

The m6A demethylase ALKBH5 promotes tumor progression by inhibiting RIG-I expression and interferon alpha production through the IKKε/TBK1/IRF3 pathway in head and neck squamous cell carcinoma

RNA demethylase ALKBH5 suppresses tumorigenesis via inhibiting proliferation and invasion and promoting CD8 + T cell infiltration in colorectal cancer

ALKBH5 Promotes Hypopharyngeal Squamous Cell Carcinoma Apoptosis by Targeting TLR2 in a YTHDF1/IGF2BP2-mediated Manner

ALKBH5 suppresses malignancy of hepatocellular carcinoma via m6A-guided epigenetic inhibition of LYPD1

Supplementary Fig. S1-13 from M<sup>6</sup>A Demethylase ALKBH5 Regulates PD-L1 Expression and Tumor Immunoenvironment in Intrahepatic Cholangiocarcinoma

M6A Demethylase ALKBH5 Regulates PD-L1 Expression and Tumor Immunoenvironment in Intrahepatic Cholangiocarcinoma

Microarray Profiling of Circular RNAs and the Potential Regulatory Role of Hsa_circ_0071410 in the Activated Human Hepatic Stellate Cell Induced by Irradiation.

ALKBH5 ameliorated liver fibrosis and suppressed HSCs activation via triggering PTCH1 activation in an m6A dependent manner

Insufficient Radiofrequency Ablation Promotes Hepatocellular Carcinoma Metastasis Through N6‐Methyladenosine mRNA Methylation‐Dependent Mechanism

RNA Demethylase ALKBH5 Inhibits TGF‐β‐induced EMT by Regulating TGF‐β/SMAD Signaling in Non‐small Cell Lung Cancer

METTL3-Mediated STING Upregulation and Activation in Kupffer Cells Contribute to Radiation-Induced Liver Disease Via Pyroptosis.

YTHDF3 mediates HNF1α regulation of cervical cancer radio‐resistance by promoting RAD51D translation in an m6A‐dependent manner

ALKBH5 promotes non-small cell lung cancer progression and susceptibility to anti-PD-L1 therapy by modulating interactions between tumor and macrophages

RNA demethylase ALKBH5 promotes colorectal cancer progression by posttranscriptional activation of RAB5A in an m6A‐YTHDF2‐dependent manner

Multi-Omics Profiling Identifies Aldehyde Dehydrogenase 2 As a Critical Mediator in the Crosstalk Between Treg-mediated Immunosuppression Microenvironment and Hepatocellular Carcinoma